Dr Rohini Mathur


Assistant Professor
of Epidemiology and Sir Henry Wellcome Postdoctoral Fellow


Keppel Street
United Kingdom

I am an epidemiologist specializing in health equity research. I initially completed an undergraduate degree in public health at the University of Waterloo in Canada, followed by an MSc at LSHTM in reproductive and sexual health research. Prior to coming to LSHTM I worked at the Institute for Health and Social Policy at McGill University in Montreal, and at later at Queen Mary, University of London, where I conducted quality improvement research focussed on identifying and tackling health inequalities across east London. From 2011-2015 I completed an ESRC funded PhD at LSHTM investigating how electronic health records can be best used to examine ethnic inequalities in health outcomes in the UK at LSHTM. A key focus of my PhD was establishing the usability and completeness of ethnicity recorded in primary and secondary care databases in order answer substantive questions around ethnic differences in major chronic disease outcomes.  


Department of Non-communicable Disease Epidemiology
Faculty of Epidemiology and Population Health


I am co-organiser for the Professional Certificate Course in Pharmacoepidemiology and Pharmacovigilance. I supervise students on the MSc. Epidemiology and MSc. Public Health.


I am currently completing a Sir Henry Wellcome Postdoctoral Fellowship examining ethnic inequalities in trajectories of diabetes risk factor control and outcomes across the health care pathway.  I am involved in collaborative work with the UK Biobank study as a member of the Diabetes Steering Group, and with the Clinical Effectiveness Group at Queen Mary, University of London.

Research Area
Health inequalities
Health services research
Primary care
Electronic health records
Disease and Health Conditions
Cardiovascular disease
Non-communicable diseases
United Kingdom

Selected Publications

Is there an association between long-term antibiotics for acne and subsequent infection sequelae and antimicrobial resistance? A systematic review protocol.
Bhate K; Lin L-Y; Barbieri J; Leyrat C; Hopkins S; Stabler R; Shallcross L; Smeeth L; Francis NA; Mathur R
BMJ open
COVID-19 in Great Britain: epidemiological and clinical characteristics of the first few hundred (FF100) cases: a descriptive case series and case control analysis
Boddington N; Charlett A; Elgohari S; Walker J; Mcdonald H; Byers C; Coughlan L; Garcia Vilaplana T; Whillock R; Sinnathamby M
Hydroxychloroquine for prevention of COVID-19 mortality: a population-based cohort study
Rentsch CT; DeVito NJ; MacKenna B; Morton CE; Bhaskaran K; Brown JP; Schultze A; Hulme WJ; Croker R; Walker AJ
Risk of 16 cancers across the full glycemic spectrum: a population-based cohort study using the UK Biobank.
Rentsch CT; Farmer RE; Eastwood SV; Mathur R; Garfield V; Farmaki A-E; Bhaskaran K; Chaturvedi N; Smeeth L
BMJ Open Diabetes Research & Care
Inhaled corticosteroid use and risk COVID-19 related death among 966,461 patients with COPD or asthma: an OpenSAFELY analysis
The OpenSAFELY Collaborative; Schultze A; Walker A; MacKenna B; Morton C; Bhaskaran K; Brown J; Rentsch C; Williamson E; Drysdale H
UK prevalence of underlying conditions which increase the risk of severe COVID-19 disease: a point prevalence study using electronic health records
Walker JL; Grint DJ; Strongman H; Eggo RM; Peppa M; Minassian C; Mansfield KE; Rentsch CT; Douglas IJ; Mathur R
Factors associated with COVID-19-related death using OpenSAFELY.
Williamson EJ; Walker AJ; Bhaskaran K; Bacon S; Bates C; Morton CE; Curtis HJ; Mehrkar A; Evans D; Inglesby P
OpenSAFELY: Do adults prescribed Non-steroidal anti-inflammatory drugs have an increased risk of death from COVID-19?
Wong AYS; MacKenna B; Morton C; Schultze A; Walker A; Bhaskaran K; Brown J; Rentsch C; Williamson E; Drysdale H
See more Publications